Quantcast
Home / Columnists / Berko / Health stocks should do well despite rising costs (access required)

Health stocks should do well despite rising costs (access required)

DEAR MR. BERKO: I like your column because it also makes me laugh, but one big criticism I have is that you never follow up to advise people when to sell the stocks you recommend. I think the Securities and Exchange Commission or the Financial Industry Regulatory Authority should require this to be standard practice ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

%d bloggers like this: